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practically free of this starter of coagulation. Thrombomodu-
lin was present at the luminal surface of all vessel segments 
and especially at venular endothelial cell junctions. Its prod-
uct, the anticoagulant protein C, appeared only at discrete 
extravascular sites, mainly next to capillaries. These distribu-
tion patterns were basically identical in the healthy and dis-
eased hearts, suggesting a general principle.  Conclusions: 
Venular extravasation of plasma proteins probably would 
not bring prothrombin into intimate contact with tissue fac-
tor, avoiding interstitial coagulation in the absence of injury. 
Generation of activated protein C via thrombomodulin is fa-
vored in the vicinity of venular gaps, should thrombin occur 
inside coronary vessels. This regionalization of distribution 
supports the proposed physiological heterogeneity of the 
vascular barrier and complies with the passage of plasma 
proteins into the lymphatic system of the heart. 
 Copyright © 2010 S. Karger AG, Basel 
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 Abstract 
 Background: Heterogeneity of vascular permeability has 
been suggested for the coronary system. Whereas arterio-
lar and capillary segments are tight, plasma proteins pass 
readily into the interstitial space at venular sites. Fittingly, 
lymphatic fluid is able to coagulate. However, heart tissue 
contains high concentrations of tissue factor, presumably 
enabling bleeding to be stopped immediately in this vital 
organ. The distribution of pro- and anti-coagulatively active 
factors in human heart tissue has now been determined in 
relation to the types of microvessels.  Methods and Results: 
Samples of healthy explanted hearts and dilated cardiomyo-
pathic hearts were immunohistochemically stained. Albu-
min was found throughout the interstitial space. Tissue fac-
tor was packed tightly around arterioles and capillaries, 
whereas the tissue surrounding venules and small veins was 
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 Introduction 
 As early as 1653, the physiologist Olaus Rudbeck had 
realized that the lymphatic fluid is capable of coagulation 
 [1, 2] . This ability makes it mandatory for plasma coagu-
lation factors to extravasate somewhere in the vascular 
bed, a fact later ignored by Ernest Starling when formu-
lating his classical concept of fluid homeostasis in the 
vasculature  [3] . In many tissues, interstitial and lymphat-
ic protein levels have been found to be far higher than 
previously assumed and, surprisingly, to have next to
no impact on fluid exchange across the capillary wall, 
provided the endothelium is endowed with an intact
glycocalyx  [4] . In fact, the oncotic gradient established
by plasma proteins across the glycocalyx from lumen to 
endothelial membrane surface determines the effective 
filtration pressure  [5] . In addition to this glycocalyx effect 
there are only very narrow strand gaps between adjoining 
endothelial cells  [4] . Thus, outward fluid filtration and 
protein passage in the arteriolar and capillary segments 
must be expected to be very low. Furthermore, contrary 
to Starling’s postulate, no net resorption occurs in the 
venular sections of the vasculature of most organs  [6] .
 We have recently described, based on studies in iso-
lated heart preparations, that the coronary bed exhibits a 
non-uniform filtration behavior, namely extremely low 
filtration and little egress of colloid in the arteriolar and 
capillary beds, as opposed to ready access of intravascular 
colloids to the interstitial space in the venular sections  [7] . 
However, with both hydrostatic and oncotic pressure gra-
dients being small in the latter segments, there is little 
driving force for fluid movement  [7] . The net result is a 
low-filtration state ‘paradoxically’ associated with high 
interstitial plasma colloid levels. 
 The physiological problem with such a condition is ev-
ident: should extravasating zymogens of plasma coagula-
tion factors meet up with their activators, then the inter-
stitial space would be plugged by fibrin. Indeed, the myo-
cardium has been reported to express high levels of tissue 
factor, one of the most potent stimuli for rapid coagula-
tion  [8, 9] and one that is normally not in direct contact 
with the bloodstream  [10] . However, the fibrinogen-
cleaving power of thrombin can be effectively countered 
in plasma by inhibitory systems, foremost activated pro-
tein C (APC). This is produced from the zymogen protein 
C by the endothelial membrane protein thrombomodu-
lin, acting in conjunction with thrombin  [11, 12] , and 
could also be passed on into tissue via the venular gaps.
 The explanation why coagulation obviously does  not 
normally occur in the interstitial space of the heart, de-
spite the proposed facile extravasation of plasma protein 
constituents, remains elusive. By staining human myo-
cardium for albumin, tissue factor, thrombomodulin and 
its anticoagulatory product APC, we sought to obtain 
histological insight into the seeming physiological para-
dox: coagulability of lymphatic fluid on the one hand, 
and pro-coagulatory tissue activity on the other. 
 Materials and Methods 
 Human heart tissue was obtained (with consent from the near-
est relatives) from two explanted healthy hearts that had, unfor-
tunately, not become available to the prospective recipients in 
time because of logistical reasons (‘healthy’), and (with prior in-
formed consent) from three ‘diseased’ organs. Two were adults 
with explantation necessitated by dilated cardiomyopathy (DCM), 
the third was a 1-year-old subject with DCM. In the latter case
we examined surgical material obtained at implantation of a left 
ventricular assist device. For the adult hearts, macroscopically 
healthy sections of the left ventricle, 4 from each individual heart, 
were finely diced with a scalpel (approx. 1–2-mm cubes) and im-
mersed in formaldehyde solution (4.5%), fixed (formalin 4.5%), 
dehydrated and embedded in paraffin. Tissue slices were deparaf-
finated and, to demask the tissue antigens, subjected to micro-
wave treatment in citrate buffer at pH 6.0 (3  ! 5 min). After 
blocking endogenous peroxidase activity (3% hydrogen peroxide, 
15 min), the sections were treated with 3% normal goat serum 
(Vector Laboratories, Burlingame, Calif., USA) or 3% porcine se-
rum (albumin staining) for 30 min.
 Staining for Human Albumin 
 Tissue slices were stained using a monoclonal mouse antibody 
against human albumin (Clone HSA-11; Sigma, St. Louis, Mo., 
USA) and then with a secondary antibody (Anti-mouse IgG, goat, 
biotinylated; Vector Laboratories; diluted 1: 50), together with a 
reaction kit (Vectastain, Vector Laboratories). Histogreen (Lina-
ris, Wertheim, Germany) served as chromogen.
 Staining for Tissue Factor and Evaluation of Distribution 
 A primary monoclonal mouse antibody against the CD 142 
epitope of tissue factor (Acris Antibodies, Hiddenhausen, Ger-
many) diluted 1: 100 was applied for 2 h at room temperature; the 
secondary antibody was diluted 1: 200. Diaminobenzidine (DAB) 
was used as chromogen together with the Vectastain kit. Tissue 
was counterstained with hematoxylin.
 Three blinded experts (M.R., D.B., P.C.) were independently 
provided with 2–5 different slices of healthy or diseased heart 
preparations and asked to first identify vessels belonging to three 
different categories: artery/arteriole, capillary and venule/vein. 
For each identified vessel they were then required to rate the in-
tensity of staining found within a 20-  m border zone of the vessel 
lumen using a decimal scale ranging from 0 (no stain) to 10 (in-
tense stain completely surrounding the vessel). The data are pre-
sented as median, smallest observation, lower and upper 95th and 
97th percentile and largest observation, with n indicating the total 
number of vessels analyzed per category. For comparisons of mul-
tiple groups, analysis of variance (ANOVA) was performed. Post 
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hoc tests were performed using the Bonferroni method. p  ! 0.05 
was considered to be significant. The statistical software used to 
conduct the analyses was SPSS 16 (SPSS Inc., Chicago, Ill., USA).
 Staining for Thrombomodulin and Protein C 
 Detection was performed according to the avidin-biotin-
horseradish-peroxidase-complex method using the Vectastain kit. 
The monoclonal antibodies to thrombomodulin (Dako, Ham-
burg, Germany) and protein C (Upstate, Lake Placid, N.Y., USA) 
were diluted 1: 100 and applied for 1 h at room temperature and 
overnight at 4  °  C. The second, biotinylated antibody (anti-mouse; 
Vector Laboratories) was diluted 1: 50 and applied for 45 min at 
room temperature. After rinsing with PBS, incubation with per-
oxidase-labeled streptavidin (45 min, room temperature), and re-
newed rinsing, peroxidase activity was visualized with DAB and 
H 2 O 2 . Tissue was counterstained with hematoxylin.
 Light microscopy was performed using a Nikon eclipse 80i 
microscope (Nikon, Düsseldorf, Germany; 20 ! objective lens, 
Nikon Plan apo, N.A. 0.75 and 40 ! objective lens, Nikon Plan, 
N.A. 0.65) The imaging medium was air, no fluorochromes were 
used and images were captured with a Nikon digital camera DS-
5M and processing in Adobe Photoshop 7.0.
 Results 
 The healthy human hearts revealed the presence of al-
bumin not only at the coronary vessel walls, but also 
throughout the interstitial space, especially the outside of 
the muscle cells, which were highly positive (see green 
color in  fig. 1 a, b). Intense staining for albumin was also 
found throughout the interstitial space of hearts with di-
lated cardiomyopathy ( fig.  1 c). Tissue factor was evi-
denced as brown, granular staining in and on various 
cells of the heart tissue, both in healthy and diseased sam-
ples. We found a high concentration of tissue factor 
around the arterioles and the capillaries, but almost none 
around the venules and small veins (see  fig. 1 d–f). Throm-
bomodulin, an endothelial inhibitor of coagulation, was 
found as expected at the luminal surface of all vessels 
( fig. 1 g–i). Staining was extremely intense at endothelial 
cell junctions in large venules (black arrowhead in  fig. 1 h). 
APC was identified around small vessels ( fig. 1 j–l). The 
localization appeared to coincide approximately with 
that of tissue factor, as noted before. No protein C stain-
ing occurred at the luminal surface of coronary vessels in 
the heart specimens examined here (cf.  fig. 1 j–l).
 Comparable distributions of tissue factor and throm-
bomodulin were found in the tissue slices obtained from 
a further healthy heart and another 2 hearts that had de-
veloped dilated cardiomyopathy ( fig. 2 ). With respect to 
tissue factor, this again proved to be localized around 
capillaries ( fig. 2 a) and to be absent from around venules 
( fig. 2 b). An intense luminal expression of thrombomod-
ulin (brown coloration) is demonstrated in  figure 2 c for 
an arteriole of 50   m diameter in a slice from a healthy 
heart. An example of dense localization of thrombomod-
ulin to a small venule is shown in  figure 2 d. 
 Although specific tissue localizations of the 3 factors 
investigated here with respect to the various categories of 
microvessel were the same for healthy and diseased 
hearts, samples obtained from the latter did show by far 
denser connective tissue. This feature is most apparent in 
 figure 1 c, i and in  figure 2 a, d when these are compared 
to the accompanying pictures of healthy tissue.
 Quantitative evaluation of the vessel-specific distribu-
tion of tissue factor, performed by expert rating, is shown 
in a box plot in  figure 3 . Both in the healthy hearts ( fig. 3 a) 
and in the diseased hearts ( fig. 3 b) there was tissue factor 
around arterioles, small arteries and capillaries, with sig-
nificantly less (practically none) around venules and 
small veins.
 Discussion 
 An important first result of the present work concerns 
the fact that the plasma protein albumin was present in 
substantial amounts within the interstitial space of all the 
myocardial tissue samples examined, irrespective of 
whether they had been derived from healthy or diseased 
organs. This supports the concept of ready extravasation 
of plasma proteins from the microvasculature under 
physiological conditions  [1, 4] , extended to the heart in 
recent studies  [7] .
 The modern, glycocalyx-dependent concept of cardiac 
vascular/interstitial fluid handling  [4, 7] , reconciling low 
fluid filtration with egress of plasma proteins, is outlined 
schematically in  figure 4 , along with supportive immu-
nohistochemical and electron microscopical findings ob-
tained on isolated perfused heart preparations. In the
arteriolar and capillary segments ( fig. 4 a), the intact endo-
thelial glycocalyx retains plasma proteins, creating an on-
cotic gradient between lumen and endothelial surface (but 
not necessarily between lumen and interstitial space, see 
below). In conjunction with narrow endothelial clefts this 
opposes the hydrostatically driven outflow of plasma. The 
net result is one of low flow, with little transport of plasma 
constituents ( fig. 4 a, top)  [4, 7] . This is evidenced by the 
absence of human albumin (green stain) in the pericapil-
lary space after brief (2 min) intracoronary application to 
isolated guinea pig hearts ( fig. 4 a, middle)  [7] . Also, the 
stain containing lanthanum and glutaraldehyde, applied 
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to preserve the endothelial glycocalyx for electron micros-
copy [13] , does not spread beyond the luminal caveolae in 
capillaries ( fig. 4 a, bottom)  [7] . In the venular segments 
( fig. 4 b), large pores between the endothelial cells allow 
free and easy access of plasma constituents to the intersti-
tial space. However, bulk plasma outflow towards this 
compartment and movement of fluid plus solutes in the 
opposite direction are low, because both the hydrostatic 
and the oncotic pressure differences are small ( fig. 4 b, top). 
Accordingly, in isolated guinea pig hearts, the intravascu-
larly applied markers albumin ( fig. 4 b, middle) and glyco-
calyx-fixative ( fig. 4 b, bottom) appear within minutes also 
in the interstitial space next to venules and small veins and 
on abluminal cell surfaces, respectively  [7] .
 Since albumin passes readily into the interstitial space, 
the same should hold true for plasma coagulation factors. 
Accordingly, we postulated that the distribution of tissue 
factor in heart tissue cannot be homogeneous, but per-
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 Fig. 1. Examples of distribution of albumin ( a– c , green stain), tissue factor ( d–f , brown stain), thrombomodulin 
( g–i , brown stain) and protein C ( j–l , brown stain) in ventricular tissue, comparing a healthy human heart (left 
and middle columns) and a heart from an adult suffering from dilated cardiomyopathy (right column). The left 
column highlights arteriolar and capillary vessels, the middle and right columns preferentially venular and 
capillary sites. a = Arteriole; v = venule;  ] = capillary;  h = junction of venular endothelial cells. 
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 Fig. 2. Examples of the distribution of tis-
sue factor ( a ,  b , brown stain) and throm-
bomodulin ( c ,  d , brown stain) in ventricu-
lar tissue of human hearts.  a ,  b ,  d Samples 
from subjects suffering from dilated car-
diomyopathy.  a One-year-old subject.  b ,
 d Adult.  b Positive staining of intravas-
cular monocytes as opposed to no stain 
around the venule.  c Thrombomodulin in 
an arteriole of 50   m diameter of a healthy 
heart. a = Arteriole; v = venule;  ] = capil-
lary. 
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 Fig. 3. Blinded expert-rated results of tissue factor immunostaining for different categories of vessels. Results 
were rated within a 20-  m border zone outside of the vessel using a decimal scale ranging from 0 (no stain) to 
10 (intense stain completely surrounding the vessel).  *  p  ! 0.05 vs. artery/arteriole.  #  p  ! 0.05 vs. other vessel 
categories;  a healthy hearts,  b diseased hearts. 
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haps localized to arteriolar and capillary sites. Here it 
would provide the useful ‘hemostatic envelope’ proposed 
for whole vital organs  [14] to ensure rapid sealing of le-
sions. Large-pore venular sections, conversely, should be 
devoid of tissue factor, allowing for intravascular/inter-
stitial exchange of fluid, solute and colloid, as well as for-
mation of lymphatic fluid with the potential to coagulate. 
Exactly such an intraorgan heterogeneity of distribution 
was observed in the present study.
 High concentrations of tissue factor around arterioles 
and capillaries, representing those vessels where the en-
dothelial glycocalyx normally prevents plasma proteins 
from leaving the vasculature  [4] , serve to initiate the ex-
trinsic pathway of blood coagulation, should factor VII 
appear. This is synonymous with trauma and, conse-
quently, immediate hemostasis via the TF/FVIIa complex 
is necessary. In contrast, the walls and interstitial space 
around the venules appear largely free of tissue factor, an 
indispensable prerequisite for maintaining physiological 
conditions according to the new concept of coronary flu-
id and protein handling  [7] . Owing to the absence of tis-
sue factor, no overwhelming coagulation should occur in 
these regions of plasma exchange with the tissue space.
 The granular staining and location of tissue factor 
around small arteries, arterioles and capillaries is remi-
niscent of the morphology and localization of pericytes 
 [15] . Some tissue factor was clearly located in cells away 
from the vascular walls, presumably cardiomyocytes. 
This has been reported already by Szotowsky et al.  [10] for 
the human heart, but no details on distribution of tissue 
factor with respect to vessel provenience were given  [10, 
14] . Tissue-specific distribution of tissue factor, taken to 
indicate additional hemostatic protection of vital organs 
 [14, 16] , is now extended to a considerable heterogeneity 
of expression already within one and the same organ.
 A powerful feedback inhibitor of prothrombin conver-
sion to thrombin is the endothelial membrane protein 
thrombomodulin  [17] , which acts by promoting the gen-
eration of APC  [11, 12] . In our hands, thrombomodulin 
proved to be a splendid marker for vessels of all types in 
the coronary system. It was always localized to the lumi-
nal surface, but particularly high staining intensity was 
found at the junctions of endothelial cells in the venular 
and small venous vessel segments. This strategic localiza-
tion would guarantee generation and passage of activated 
protein C into the interstitial space should any thrombin 
Arteriolar/capillary segments            Venular segments
Vascular lumen
Endothelial cell
Interstitial space
Glycocalyx
Glycocalyx
Cleft
Interstitial space
Large
pore
20 μm
10 μm1 μm
50 μm
*
a b
 Fig. 4. The low-filtration concept of car-
diac vascular/interstitial fluid handling. 
Schematic illustration (top panels), local-
ization of infused albumin (middle panels, 
green color) and electron microscopical 
appearance of guinea pig hearts perfused 
with fixative for the glycocalyx (bottom 
panels, black stain), all as described previ-
ously  [7, 13] . Fixation of the glycocalyx en-
tailed coronary perfusion over 1 min with 
4 ml buffer solution containing 2% lantha-
num nitrate, 2% glutaraldehyde, 2% su-
crose and 0.1 moles/l of sodium cacodylate 
(pH 7.4). Heart tissue was then diced and 
left in this fixative for 2 h before being 
transferred into solution without glutaral-
dehyde for overnight fixation. The arrows 
indicate capillaries, the asterisk shows a 
venule. 
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activity be present in the luminal plasma zone. APC is not 
only an anticoagulant but, via binding to cell membrane 
protein C receptors, may also initiate anti-inflammatory 
and anti-apoptotic effects. Important with respect to de-
tecting localization in tissue is that receptor-bound APC 
will have higher permanence during staining and wash-
ing procedures. The antibody used by us in the present 
work was directed against the heavy chain of protein C 
and, therefore, recognizes both zymogen protein C and 
APC  [18] . Heart tissue only stained for protein C at dis-
crete extraluminal sites, noteworthy being the fact that 
these were sites that had proved typical for the localiza-
tion of tissue factor (cf.  fig. 1 d–f, j–l). It is, therefore, 
tempting to assume that APC is gathered there where the 
greatest risk exists for thrombin to be accidentally gener-
TF Tissue factor Thrombomodulin Activated protein C
‘Large pore’ venular sections
Easy egress of plasma proteins,
‘back diffusion’ is possible
very low filtration rate
(glycocalyx + narrow strand gaps)
[Pv – PT] small, [v – T] small
low filtration rate
IS
ESL e
g
g
c
TF
TF
TF
TF
EC
TF
PT T
V
Capillary segments (continuous)
Hardly any egress of plasma proteins,
small flow of ultrafiltrate
Pv
ated in the interstitial space. This ‘colocalization’ of APC 
to tissue factor would thwart any untoward cleavage of 
fibrinogen under normal physiological conditions.
 A shortcoming in our work is that, to date, we have in-
vestigated only few human hearts: 2 healthy hearts and 3 
suffering from dilated cardiomyopathy. However, it is ex-
tremely difficult to get permission for human heart tissue 
to be immediately immersion-fixed after death. Although 
the dilated hearts obtained from the adults presented with 
marked tissue fibrosis, there were no apparent differences 
between the healthy and diseased hearts (including the 
heart pieces sampled from the 1-year-old subject with 
DCM) concerning the respective distributions of the co-
agulatively active factors investigated here. The presence 
of tissue factor in DCM heart tissue has been reported be-
 Fig. 5. Schematic outline of the distribu-
tion of pro-coagulatory (tissue factor, TF) 
and anti-coagulatory activity (thrombo-
modulin and activated protein C) in hu-
man heart tissue in relation to vascular 
provenience. EC = Endothelial cell; ESL = 
endothelial surface layer; IS = interstitial 
space;  c = oncotic pressure in the vascular 
lumen of a capillary;  e = oncotic pressure 
within the endothelial glycocalyx;  g = on-
cotic pressure beneath the glyco calyx;  T = 
oncotic pressure in the tissue; P T = hydro-
static pressure in the tissue;  v = oncotic 
pressure in the vascular lumen of a venule; 
P v = hydrostatic pressure in the vascular 
lumen of a venule. 
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fore  [10] and the similarity of distribution in all 5 hearts, 
despite the very diverse clinical histories, suggests a gen-
eral principle. Indeed, functional heart disease should not 
lead to a change in the principle physiology of microvas-
cular fluid exchange in the coronary system.
 The pattern of distribution in relation to the three cat-
egories of microvascular coronary vessels (small arteries/
arterioles, capillaries and venules/small veins) resulting 
from our immunohistological findings is schematically 
outlined in  figure 5 . The distributions of tissue factor 
(around arterial and early capillary sections), thrombo-
modulin (on all vessel surfaces and particularly dense at 
venular endothelial cell junctions) and protein C (adventi-
tial side of arterioles, capillaries and early venules) support 
the new perspective on microvascular fluid handling, at 
least in the myocardial tissue  [7] . This new evidence fur-
ther questions the classic view of Starling and supports a 
crucial, but probably not uniform, role of the endothelial 
glycocalyx for barrier function throughout the vascular 
bed of a whole organ. Moreover, in view of the heteroge-
neous distribution of pro- and anticoagulant factors, one 
may expect flow of interstitial fluid containing clotting 
factors to be regulated, with predetermined, preferential 
paths proceeding ‘safely’ to the terminal lymphatic ori-
gins. Indeed, such non-random, organized pathways of 
 interstitial fluid movement should comply with another 
property of myocardial vessel anatomy, namely the report-
ed parallel arrangement of arterioles and venules  [19] . It 
certainly would not do for prothrombin and fibrinogen 
passing from venules to impinge directly onto tissue factor 
around arterioles ( fig. 5 ). However, with APC present in 
the protein mixture introduced into the interstitium, as 
suggested in  figure 5 , the spatial proximity of arterioles 
and venules (separated by more than 500   m anyway  [19] ) 
may not be such a problem under normal conditions of 
fluid homeostasis and plasma hemostasis.
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